Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 29773-29774 [2014-11978]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 100 / Friday, May 23, 2014 / Notices
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
3, 2001, renewed at appropriate intervals,
and will expire on August 3, 2015.
Purpose: This Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters For Discussion: The agenda for the
conference call includes: Final Vote Tally for
Joslyn Manufacturing Plant and Nuclear
Metals Inc. SEC Petition Actions; Work
Group Site Profile Review Assignments; SEC
Petitions Update for the July 2014 Advisory
Board Meeting; Plans for the July 2014
Advisory Board Meeting; and Advisory Board
Correspondence.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Theodore M. Katz, M.P.A., Designated
Federal Officer, NIOSH, CDC, 1600 Clifton
Road, NE., Mailstop: E–20, Atlanta, Georgia
30333, Telephone (513) 533–6800, Toll Free
1–800–CDC–INFO, Email ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–11966 Filed 5–22–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Reducing Youth Exposure to
Alcohol Marketing, Special Interest
Projects (SIP)14–009, Panel A, initial
review.
This document corrects a
notice that was published in the Federal
Register on April 25, 2014 (79 FR
SUMMARY:
VerDate Mar<15>2010
18:44 May 22, 2014
Jkt 232001
22975). The time and date should read
as follows:
Time and Date: 10 a.m.–5 p.m., June
17, 2014 (Closed).
FOR FURTHER INFORMATION CONTACT: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway,
NE., Mailstop F46, Atlanta, Georgia
30341, Telephone: (770) 488–3585,
EEO6@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–11977 Filed 5–22–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Institute for Occupational
Safety and Health (BSC, NIOSH)
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Time and Date: 8:30 a.m.—3:00 p.m., June
20, 2014.
Place: Patriots Plaza I, 395 E Street, SW.,
Room 9200, Washington, DC 20201.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 33 people. If
you wish to attend in person or by webcast,
please see the NIOSH Web site to register
(https://www.cdc.gov/niosh/bsc/) or call (404)
498–2539 at least 48 hours in advance for
building access information. Teleconference
is available toll-free; please dial (888) 397–
9578, Participant Pass Code 63257516.
Purpose: The Secretary, the Assistant
Secretary for Health, and by delegation the
Director, Centers for Disease Control and
Prevention, are authorized under Sections
301 and 308 of the Public Health Service Act
to conduct directly or by grants or contracts,
research, experiments, and demonstrations
relating to occupational safety and health and
to mine health. The Board of Scientific
Counselors shall provide guidance to the
Director, National Institute for Occupational
Safety and Health on research and prevention
programs. Specifically, the Board shall
provide guidance on the Institute’s research
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
29773
activities related to developing and
evaluating hypotheses, systematically
documenting findings and disseminating
results. The Board shall evaluate the degree
to which the activities of the National
Institute for Occupational Safety and Health:
(1) Conform to appropriate scientific
standards, (2) address current, relevant
needs, and (3) produce intended results.
Matters for Discussion: NIOSH Director
Update; Implementation of the National
Academies Program Recommendations,
NIOSH Disaster Science Research Initiative
to Enhance Responder Safety and Health, and
the NIOSH Center for Motor Vehicle Safety.
Agenda items are subject to change as
priorities dictate. An agenda is also posted on
the NIOSH Web site (https://www/cdc/gov/
niosh/bsc).
Contact Person for More Information: John
Decker, Designated Federal Officer, BSC,
NIOSH, CDC, 1600 Clifton Road, NE., MS–
E20, Atlanta, Georgia 30329–4018, telephone
(404) 498–2500, fax (404) 498–2526.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–11967 Filed 5–22–14; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Nutrition and Obesity Policy
Research and Evaluation Network
(NOPREN) Coordinating Center, Special
Interest Projects (SIP)14–026, and
Nutrition and Obesity Policy Research
and Evaluation Network (NOPREN)
Collaborating Center, SIP14–027, Panel
M, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Times and Dates:
9:30 a.m.–6 p.m., June 19, 2014 (Closed)
9:30 a.m.–6 p.m., June 20, 2014 (Closed)
Place: Teleconference
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
E:\FR\FM\23MYN1.SGM
23MYN1
29774
Federal Register / Vol. 79, No. 100 / Friday, May 23, 2014 / Notices
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Nutrition and Obesity Policy Research
and Evaluation Network (NOPREN)
Coordinating Center, (SIP)14–026, and
Nutrition and Obesity Policy Research
and Evaluation Network (NOPREN)
Collaborating Center, SIP14–027, Panel
M, initial review.’’
Contact Person for More Information:
M. Chris Langub, Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F–80, Atlanta,
Georgia 30341, Telephone: (770) 488–
3585, EEO6@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–11978 Filed 5–22–14; 8:45 am]
BILLING CODE 4163–18–P
response to ‘‘Miner Safety and Health
Training Program—Western United States
(U60) RFA–OH–14–004,’’ initial review.
Contact Person for More Information:
George Bockosh, M.S., Scientific Review
Officer, CDC/NIOSH, 1600 Clifton Road,
Mailstop E–74, Atlanta, Georgia 30333,
Telephone: (412) 386–6465.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–11969 Filed 5–22–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3291–N]
Announcement of the Re-Approval of
AABB (Foremerly Known as the
American Association of Blood Banks)
as an Accreditation Organization
Under the Clinical Laboratory
Improvement Amendments of 1988
Centers for Medicare &
Medicaid Services (CMS), HHS.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
Centers for Disease Control and
Prevention
ACTION:
mstockstill on DSK4VPTVN1PROD with NOTICES
The meeting announced below
concerns Miner Safety and Health
Training Program—Western United
States (U60) RFA–OH–14–004, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 1:00 p.m.–4:00 p.m., June
16, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
18:44 May 22, 2014
Jkt 232001
This notice announces the
application of AABB for approval as an
accreditation organization for clinical
laboratories under the Clinical
Laboratory Improvement Amendments
of 1988 (CLIA) program. We have
determined that AABB meets or exceeds
the applicable CLIA requirements. In
this notice, we announce the approval
and grant AABB deeming authority for
a period of 6 years. This deeming
authority is granted to AABB for the
Blood Bank and Transfusion Service
(BB/TS) program, the
Immunohematology Reference
Laboratory (IRL) program, the Molecular
Testing (MT) program, and the Cellular
Therapy (CT) program.
SUMMARY:
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
VerDate Mar<15>2010
Notice.
Effective Date: This notice is
effective from May 23, 2014 to May 25,
2020.
DATES:
FOR FURTHER INFORMATION CONTACT:
Daralyn Hassan, 410–786–9360.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
I. Background and Legislative
Authority
On October 31, 1988, the Congress
enacted the Clinical Laboratory
Improvement Amendments of 1988
(CLIA) (Pub. L. 100–578). CLIA
amended section 353 of the Public
Health Service Act. We issued a final
rule implementing the accreditation
provisions of CLIA on July 31, 1992 (57
FR 33992). Under those provisions, we
may grant deeming authority to an
accreditation organization if its
requirements for laboratories accredited
under its program are equal to or more
stringent than the applicable CLIA
program requirements in 42 CFR part
493 (Laboratory Requirements). Subpart
E of part 493 (Accreditation by a Private,
Nonprofit Accreditation Organization or
Exemption Under an Approved State
Laboratory Program) specifies the
requirements an accreditation
organization must meet to be approved
by CMS as an accreditation organization
under CLIA.
II. Notice of Approval of AABB as an
Accreditation Organization
In this notice, we approve AABB as
an organization that may accredit
laboratories for purposes of establishing
their compliance with CLIA
requirements for the following specialty
and subspecialty areas under CLIA:
• Microbiology, including
Bacteriology, Mycology, and Virology.
• Diagnostic Immunology, including
Syphilis Serology, General Immunology.
• Chemistry, including Routine
Chemistry, Urinalysis, Toxicology.
• Hematology.
• Immunohematology, including
ABO Group & Rh Group, Antibody
Detection, Antibody Identification,
Compatibility Testing.
We have examined the initial AABB
application and all subsequent
submissions to determine its
accreditation program’s equivalency
with the requirements for approval of an
accreditation organization under
subpart E of part 493. We have
determined that AABB meets or exceeds
the applicable CLIA requirements. We
have also determined that AABB will
ensure that its accredited laboratories
will meet or exceed the applicable
requirements in subparts H, I, J, K, M,
Q, and the applicable sections of R.
Therefore, we grant AABB approval as
an accreditation organization under
subpart E of part 493, for the period
stated in the DATES section of this notice
for the submitted specialty and
subspecialty areas under CLIA. As a
result of this determination, any
laboratory that is accredited by AABB
E:\FR\FM\23MYN1.SGM
23MYN1
]]>Agencies
[Federal Register Volume 79, Number 100 (Friday, May 23, 2014)]
[Notices]
[Pages 29773-29774]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11978]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Nutrition and Obesity Policy
Research and Evaluation Network (NOPREN) Coordinating Center, Special
Interest Projects (SIP)14-026, and Nutrition and Obesity Policy
Research and Evaluation Network (NOPREN) Collaborating Center, SIP14-
027, Panel M, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Times and Dates:
9:30 a.m.-6 p.m., June 19, 2014 (Closed)
9:30 a.m.-6 p.m., June 20, 2014 (Closed)
Place: Teleconference
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the
[[Page 29774]]
Determination of the Director, Management Analysis and Services Office,
CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Nutrition and Obesity Policy Research and Evaluation Network
(NOPREN) Coordinating Center, (SIP)14-026, and Nutrition and Obesity
Policy Research and Evaluation Network (NOPREN) Collaborating Center,
SIP14-027, Panel M, initial review.''
Contact Person for More Information: M. Chris Langub, Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-80,
Atlanta, Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-11978 Filed 5-22-14; 8:45 am]
BILLING CODE 4163-18-P
